IPG Investment Advisors’s scPharmaceuticals SCPH Stock Holding History

IPG Investment Advisors’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-12,000	Closed	-$31.6K	–	201
2025 Q1	$31.6K	Hold	12,000	–	–	0.01%	166
2024 Q4	$42.5K	Hold	12,000	–	–	0.01%	169
2024 Q3	$54.7K	Hold	12,000	–	–	0.01%	168
2024 Q2	$52.2K	Hold	12,000	–	–	0.01%	168
2024 Q1	$60.2K	Hold	12,000	–	–	0.01%	159
2023 Q4	$75.2K	Buy	+12,000	New	+$68.7K	0.02%	182
2023 Q1	–	Sell	-14,300	Closed	-$103K	–	175
2022 Q4	$103K	Hold	14,300	–	–	0.03%	126
2022 Q3	$93.2K	Hold	14,300	–	–	0.03%	127
2022 Q2	$69K	Hold	14,300	–	–	0.02%	142
2022 Q1	$81K	Hold	14,300	–	–	0.02%	158
2021 Q4	$72K	Buy	+14,300	New	+$78.7K	0.01%	196

Other funds holding SCPH

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

IPG Investment Advisors's SCPH Position: Q2 2025 in Review

IPG Investment Advisors sold out of scPharmaceuticals (SCPH) in Q2 2025, closing a stake of 12,000 shares — an estimated $31.6K sold.

IPG Investment Advisors first reported a position in SCPH in Q4 2021 and held it in 11 quarters. The position peaked at $103K in Q4 2022. 97 funds tracked by Wall St. Rank hold SCPH as of Q2 2025.

IPG Investment Advisors reported no remaining scPharmaceuticals position as of Q2 2025 after selling out during the quarter.
IPG Investment Advisors sold 12,000 scPharmaceuticals shares in Q2 2025, an estimated $31.6K.
IPG Investment Advisors first reported a position in scPharmaceuticals in Q4 2021 and held it in 11 quarters.
IPG Investment Advisors's scPharmaceuticals position peaked at $103K in Q4 2022.
97 funds tracked by Wall St. Rank held scPharmaceuticals as of Q2 2025.

Based on IPG Investment Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.